Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Emmaus Life Sciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $30.15M | $30.15M - $30.15M | -$5.28M | $0.06 | 1 |
| Dec 2024 | $21.00M | $21.00M - $21.00M | -$3.68M | $0.04 | 1 |
| Dec 2023 | $20.00M | $20.00M - $20.00M | -$2.19M | -$0.07 | 1 |
| Dec 2022 | $19.00M | $19.00M - $19.00M | -$2.08M | -$0.06 | 1 |
| Dec 2021 | $23.00M | $23.00M - $23.00M | -$2.52M | $0.03 | 1 |
| Dec 2020 | $5.08M | $5.08M - $5.08M | -$556.1K | -$2.88 | 1 |
| Dec 2019 | $2.28M | $2.28M - $2.28M | -$249.9K | -$5.58 | 1 |
| Dec 2018 | $1.44M | $1.44M - $1.44M | -$158.0K | -$11.22 | 1 |
| Dec 2017 | $323.0K | $323.0K - $323.0K | -$35.4K | -$11.94 | 1 |